Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06362369
Status:
RECRUITING
Last Update Posted:
2024-05-31
First Post:
2024-03-21
Brief Title:
A Study of Oral 7HP349 Alintegimod in Combination with Ipilimumab Followed by Nivolumab Monotherapy
Sponsor:
7 Hills Pharma LLC
Organization:
7 Hills Pharma LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-21
First Submit QC Date:
April 11 2024
Study First Post Date:
2024-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-11
Last Update Post Date:
2024-05-31
Last Update Post Date Type:
ACTUAL